135 related articles for article (PubMed ID: 30275215)
1. Prognostic Significance and Clinicopathological Features of Synchronous Colorectal Cancer.
Arakawa K; Hata K; Nozawa H; Kawai K; Tanaka T; Nishikawa T; Sasaki K; Shuno Y; Kaneko M; Hiyoshi M; Emoto S; Murono K; Sonoda H; Ishihara S
Anticancer Res; 2018 Oct; 38(10):5889-5895. PubMed ID: 30275215
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Histologic Type in Curatively Resected Stage IV Colorectal Cancer: A Japanese Multicenter Retrospective Study.
Shibata J; Kawai K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Sugihara K; Watanabe T
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S621-9. PubMed ID: 26350364
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of synchronous colorectal carcinoma compared to solitary colorectal carcinoma: a matched pair analysis.
He W; Zheng C; Wang Y; Dan J; Zhu M; Wei M; Wang J; Wang Z
Eur J Gastroenterol Hepatol; 2019 Dec; 31(12):1489-1495. PubMed ID: 31441800
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Synchronous Colorectal Adenocarcinoma: A Matched-Pair Analysis.
Anannamcharoen S; Nimmanon T; Cheeranont P; Boonya-Ussadorn C
Asian Pac J Cancer Prev; 2024 May; 25(5):1539-1545. PubMed ID: 38809625
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
[TBL] [Abstract][Full Text] [Related]
7. Synchronous polyps predict metachronous colorectal lesions after curative resection of colorectal cancer.
Pozza A; Ruffolo C; Fiorot A; Padoan L; Erroi F; Massani M; Caratozzolo E; Bonariol L; Ferrara F; Norberto L; Castoro C; Bassi N; Scarpa M
Acta Chir Belg; 2016 Aug; 116(4):225-230. PubMed ID: 27426670
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
[TBL] [Abstract][Full Text] [Related]
9. Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer.
Ahmed S; Leis A; Chandra-Kanthan S; Fields A; Zaidi A; Abbas T; Le D; Reeder B; Pahwa P
Ann Surg Oncol; 2016 Jul; 23(7):2287-94. PubMed ID: 27016291
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological analysis of 39 patients with multiple primary synchronous colorectal carcinoma].
Fang P; Qian F; Wu JZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Nov; 10(6):535-9. PubMed ID: 18000774
[TBL] [Abstract][Full Text] [Related]
11. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050
[TBL] [Abstract][Full Text] [Related]
12. Treatment and Outcome of Synchronous Colorectal Carcinomas: A Nationwide Study.
Bos ACRK; Matthijsen RA; van Erning FN; van Oijen MGH; Rutten HJT; Lemmens VEPP
Ann Surg Oncol; 2018 Feb; 25(2):414-421. PubMed ID: 29159744
[TBL] [Abstract][Full Text] [Related]
13. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
14. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.
Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H
Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240
[TBL] [Abstract][Full Text] [Related]
15. Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment.
Ott C; Gerken M; Hirsch D; Fest P; Fichtner-Feigl S; Munker S; Schnoy E; Stroszczynski C; Vogelhuber M; Herr W; Evert M; Reng M; Schlitt HJ; Klinkhammer-Schalke M; Teufel A
Digestion; 2018; 98(3):143-152. PubMed ID: 29870979
[TBL] [Abstract][Full Text] [Related]
16. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological studies and patterns of recurrence of mucinous colorectal carcinoma with curative resection].
Higuchi T; Kobayashi H; Ishikawa T; Ishiguro M; Iida S; Uetake H; Enomoto M; Sugihara K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2560-2. PubMed ID: 21224639
[TBL] [Abstract][Full Text] [Related]
18. Is there a prognostic value of tumor location among Chinese patients with colorectal cancer?
Liu F; Li C; Jia H; Yang L; Wu Y; Zhao J; Cai S; Zhu J; Xu Y
Oncotarget; 2017 Jun; 8(24):38682-38692. PubMed ID: 28418874
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in the patients with T2N0M0 colorectal cancer.
Xu B; Yu L; Zhao LZ; Ma DW
World J Surg Oncol; 2016 Mar; 14():76. PubMed ID: 26965721
[TBL] [Abstract][Full Text] [Related]
20. A high preoperative carbohydrate antigen 19-9 level is a risk factor for recurrence in stage II colorectal cancer.
Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Murono K; Watanabe T
Acta Oncol; 2017 May; 56(5):634-638. PubMed ID: 27885879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
